4 indicted Broward Health execs reject plea deal

Lawyers for at least four of five former Broward Health executives on Jan. 17 rejected plea deals to reduce the charges against them for allegedly violating Florida state law in 2017, the Sun Sentinel reports.

Advertisement

Three things to know:

1. During a hearing Jan. 17, lawyers for four of the five defendants said their clients were planning to or were likely to turn down a proposal from prosecutors that would have reduced the charges levied against them to one or two noncriminal infractions, fines and prosecution costs, according to the report.

2. The defendants — three former board members, a current board member and the Fort Lauderdale, Fla.-based health system’s former general counsel — were indicted in December 2017 for allegedly violating the state’s open-meetings act by holding private meetings during which they decided to oust former Broward Health CEO Pauline Grant.

3. All five defendants maintain they did not violate any state laws. Their trial is expected to begin April 9.

To access the full report, click here.

More articles on legal and regulatory issues:
Florida Hospital can dismiss claims it acted as debt collector, judge says
UPMC employees must pay system $317K after withdrawing wage lawsuit
Ex-hospital CEO imprisoned for kickback scheme breaches plea deal

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.